retatrutide diabetes type 2 phase trial obesity triple agonist for hormone receptor metabolic dysfunction-associated steatotic liver disease: a randomized 2a Retatrutide is gaining attention in – retatrutide clinical trial outcomes The – Retatrutide for Weight Loss: TRIUMPH-1

Consult with your doctor to discuss whether retatrutide or tirzepatide is right for you

Yes, attendees will receive a certificate of attendance upon successfully completing the course

That question is at the center of everything that follows in this series

The 23 online screens cover demographics, comorbidities, family and surgery history, medications, allergies, lifestyle, race/ethnicity, and address but they do not ask the GLP-1-specific FDA-black-box questions (MTC, MEN-2, pancreatitis personal history) and they do not let the patient select a medication

High potassium levels (hyperkalemia) or low potassium levels (hypokalemia)